Howard R. Krauss, MD, elected Vice President of the Medical Board of California
by Zara Jethani
Howard R. Krauss, MD, has been elected Vice President of the Medical Board of California, reported in an official state announcement released November 13, 2020. In his role, he will, in collaboration with the President, and as a member of the Executive Committee, oversee various...
The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg
by Anthony Effinger
If you believe you are experiencing a medical or life-threatening emergency Call 911 immediately. Do not rely on communication through this website for urgent medical needs. The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons...
Multiple Sclerosis – A New Treatment, A New Hope
by Guest Author
A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....
Optimizing Brain Health During COVID
by William Buxton
As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.
Clinical Trials Round-Up: November 2020
by Mini Gill
Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...
Last updated: November 17th, 2020